About Catalent
Located at 14 School House Road in Franklin Township, New Jersey, Catalent Pharmaceutical Labs leads drug development and manufacturing in the United States. The facility provides:
- Production of 1.2 billion Zydis ODT doses annually
- Freeze-dried oral solid dosage development
- Cell and gene therapy solutions
- Clinical supply chain management
- Integrated pharmaceutical development
With state-of-the-art facilities in New Jersey and worldwide locations, Catalent delivers end-to-end solutions from early-phase development through commercial manufacturing.
Frequently asked questions
Catalent provides the following pharmaceutical development services:
- Drug Development
- Oral biologics development
- Cell and gene therapy
- Clinical trial materials
- Consumer health solutions
- Manufacturing
- Zydis ODT technology production
- Contract manufacturing
- Clinical supply manufacturing
- Technology Solutions
- Freeze-dried oral formulations
- Drug delivery systems
- Xpress Pharmaceutics® platform
The Swindon facility produces 1.2 billion Zydis ODT doses annually.
Catalent’s capabilities include:
| Category | Features |
|---|---|
| Drug Development |
|
| Manufacturing |
|
| Clinical Services |
|
Catalent maintains a global network of facilities and capabilities:
- Manufacturing Sites
- Swindon, UK – Zydis ODT production
- Multiple worldwide locations
- Regional development centers
- Service Coverage
- North America operations
- European facilities
- Asia-Pacific presence
- Supply Chain Network
- Clinical trial distribution
- Global logistics solutions
- Temperature-controlled shipping
More details about Catalent
Leading CDMO partner in pharmaceutical innovation
Catalent stands as a primary partner for pharmaceutical, biotech, and consumer health companies. Based in Franklin Township, New Jersey, the company operates as a cosmetic lab and pharmaceutical development center, delivering solutions across multiple healthcare sectors.
Advanced technology and manufacturing capabilities
The company’s expertise centers on drug delivery technology, notably through their Zydis ODT system – a freeze-dried oral dosage form that dissolves without water. Their Swindon facility alone produces 1.2 billion ODT doses yearly for both prescription and over-the-counter products.
Service spectrum and development solutions
Operating from their New Jersey headquarters, Catalent provides:
- Oral biologics development
- Cell and gene therapy solutions
- Clinical supply management
- Consumer health products
- Xpress Pharmaceutics® for accelerated Phase 1 trials
Global reach and manufacturing network
While anchored in the United States pharmaceutical sector, Catalent maintains worldwide facilities that support:
- Pharmaceutical manufacturing operations
- Clinical trial supply chains
- Biotech solution development
- Contract manufacturing services
Research and development focus
From their Franklin Township facility, Catalent coordinates their research initiatives, emphasizing innovative drug development processes and clinical supply solutions. Their integrated approach combines manufacturing expertise with advanced research capabilities, positioning them as a key player in the U.S. pharmaceutical industry.
Company gallery
